Surgical Breast Resection With or Without Axillary Lymph Node Excision in Treating Women With Breast Cancer

Phase 3

Terminated

• Conditions: Breast Cancer

• Registration Number: NCT00210236
• Lead Sponsor: Institut Bergonié

Brief Summary

This randomized phase III trial is studying surgery and axillary lymph node dissection to evaluate if systematic axillary node clearance can be avoided in locoregional treatment for operable breast cancer smaller than 10 mm among menopausal women older than 50

Detailed Description

Not available

Study Timeline

• Study Start: 1995-09
• Study First Submitted: 2005-09-12
• Study First Submitted QC: 2005-09-13
• Study First Posted: 2005-09-21
• Study Completion: 2005-12
• Status Verified: 2007-10
• Last Update Submitted: 2013-07-25
• Last Update Posted: 2013-07-26

Recruitment & Eligibility

• Status: TERMINATED
• Sex: Female
• Target Recruitment: 592

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Overall Survival (5 years)

Secondary Outcome Measures

Name	Time	Method
Cancer Survival (5 years)
Axillary recurrence (5 years)

Trial Locations

Locations (14)

Centre Hospitalier Universitaire d'Agen; 🇫🇷 Agen, France

Centre Régional de Lutte Contre le Cancer d'Anger; 🇫🇷 Angers, France

Institut Bergonié - Centre Régional de Luttre Contre le Cancer de Bordeaux et du Sud Ouest; 🇫🇷 Bordeaux, France

Centre Régional de Luttre Contre le Cancer de Clermont Ferrand; 🇫🇷 Clermont Ferrand, France

Centre Régional de Luttre Contre le Cancer de Dijon; 🇫🇷 Dijon, France

Centre Régional de Luttre Contre le Cancer de Lille; 🇫🇷 Lille, France

Centre Régional de Lutte Contre le Cancer de Lyon; 🇫🇷 Lyon, France

Centre Hospitalier Intercommunal de Marmande; 🇫🇷 Marmande, France

Centre Régional de Luttre Contre le Cancer de Montpellier; 🇫🇷 Montpellier, France

Clinique de la Source; 🇫🇷 Orléans, France

Scroll for more (4 remaining)